<DOC>
	<DOCNO>NCT01593163</DOCNO>
	<brief_summary>Patent ductus arteriosus ( PDA ) common condition immature newborn baby associate morbidity mortality . Ibuprofen drug choice PDA treatment accord last version Cochrane review . Nowadays best dose regimen ibuprofen remain uncertain . The investigator aim perform randomize controlled clinical trial ass whether echocardiographically guide PDA ibuprofen treatment versus standard treatment could reduce number dos ibuprofen without increase reopen rate reduce side effect associate medication .</brief_summary>
	<brief_title>Echocardiographically Guided Versus Standard Ibuprofen Treatment Patent Ductus Arteriosus</brief_title>
	<detailed_description>Patent ductus arteriosus ( PDA ) present 55 70 % preterm infant gestational age lower 30 week birth weight low 1000 gram . PDA associate mortality morbidity ischemic hemorrhagic cerebral event , necrotising enterocolitis , renal disfunction poor pulmonary outcome ; however , clear whether consequence PDA presence , treatment implement closing , immaturity population . PDA standard treatment ( ST ) consist three dos indomethacin ibuprofen ( 10-5-5mg/kg ) give 24 hour apart , surgical closure second line therapeutic option . In spite ibuprofen point drug choice PDA treatment last version Cochrane review , side effect associate medication . Standard ibuprofen treatment base clinical trial three-dose protocol seem effective one-dose scheme PDA closure ; however , sample size power find difference statistically significant , nowadays best dose regimen ibuprofen remain uncertain . Functional echocardiographic assessment spread world . In scenario , propose implementation guide PDA treatment order individualize number dos indomethacin administer function patient 's response , limit dos side effect PDA present early constriction . The investigator hypothesize whether echocardiographically guide PDA ibuprofen treatment could reduce number dos ibuprofen without increase reopen rate reduce side effect associate medication .</detailed_description>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Preterm infant gestational age lower 37 week gestational age PDA â‰¥ 1.5 mm No contraindication receive ibuprofen Informed consent sign . Lifethreatening congenital defect Congenital heart disease Contraindication ibuprofen administration oligoanuria &lt; 1cc/kg/h recent severe intraventricular bleeding ( IVH grade III ) creatinine serum level &gt; 1.5 mg/dl potential intestinal ischemia . Informed consent refuse</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Month</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Functional echocardiography</keyword>
	<keyword>power Doppler cranial ultrasonography</keyword>
	<keyword>N-terminal probrain natriuretic peptide</keyword>
	<keyword>Patent ductus arteriosus</keyword>
</DOC>